532983:BOM
RPG Life Sciences Ltd
2.882,00 ₹
arrow_downward
-1,88%(-55,10) 1d
7 d’oct., 14:24:23 GMT+5:30 · INR
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a 532983...
Obre
2.937,10 ₹
Alt
2.950,35 ₹
Baix
2.881,00 ₹
Capitalització borsària
48,39 kM
Volum mitjà
1,57 k
Volum
401,00
Dividend
0,83 %
Dividend trimestral
6,00 ₹
Data de l'exdividend
9 de jul. 2026
Ràtio preu-benefici
39,84
Alt 52 setmanes
3.130,50 ₹
Baix 52 setmanes
1.731,25 ₹
BPA
72,34 ₹
Accions en circulació
16,54 M
Nombre d'empleats
1 k
Obre
2.937,10 ₹
Alt
2.950,35 ₹
Baix
2.881,00 ₹
Capitalització borsària
48,39 kM
Volum mitjà
1,57 k
Volum
401,00
Dividend
0,83 %
Dividend trimestral
6,00 ₹
Data de l'exdividend
9 de jul. 2026
Ràtio preu-benefici
39,84
Alt 52 setmanes
3.130,50 ₹
Baix 52 setmanes
1.731,25 ₹
BPA
72,34 ₹
Accions en circulació
16,54 M
Nombre d'empleats
1 k
Notícies
De fonts web i partners de notícies
Reuters Connect
·
fa 11 hores
Licensable video: Wall Street cierra al alza y el S&P 500 y el Nasdaq marcan nuevos máximos históricos
Simply Wall Street
·
fa 29 minuts
Why Is Micron Technology (MU) Paying $600 Million To End Its Patent Fight?
The Motley Fool
·
fa 5 minuts
The S&P 500 Just Had One of Its Strangest Months in Years. History Says This Usually Doesn't Last.
MarketBeat
·
fa 21 minuts
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Stock Has Average Target Price of $3.90
Perfil
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
Sobre RPG Life Sciences Ltd